logo

SYRE

Spyre Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.96 / 10
Underperform

Technically, SYRE is underperforming (score 2.96/10). Dominated by three bearish signals—MACD Death Cross (score 1), Long Upper Shadow (score 3.36), and Marubozu White (score 2.75)—the chart shows limited upside momentum. Only the MACD Golden Cross (score 4.73) offers a neutral counterweight. Recent five-day data confirm a weak trend with no bullish indicators and a high bearish count (3 vs. 0), highlighting downside risk.

FundamentalSentimentTechnical(2.96)

Analysis Checks(0/4)

Long Upper Shadow
Score3.36/10
Win Rate50.00%
Hist. Signals40
Avg Return0.73%
MACD Death Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-4.53%
MACD Golden Cross
Score4.73/10
Win Rate50.00%
Hist. Signals8
Avg Return2.69%
Marubozu White
Score2.75/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.40%
What is the current technical signals for SYRE?
  • SYRE presents a Underperform setup with a Technical Score of 2.96/10. Key technical indicators highlight an RSI of 60.77 and a MACD of 0.06, with the trend anchored by the 50-Day SMA at 32.48. Traders should monitor key support at 31.67 and resistance at 33.94.